Skip to content
Governance Register

← US public companies

Acrivon Therapeutics, Inc.

SEC CIK 1781174 · ACRV · last insider filing 2026-06-22

Directors (from insider filings)

NameCapacity as filedFilings
Magovcevic-Liebisch Ivana Director filed 2024 - 2026
RA Capital Healthcare Fund LP Director filed 2022 - 2026
RA Capital Management, LLC Director filed 2022 - 2026
Kolchinsky Peter Director filed 2022 - 2026
Tomsicek Michael John Director filed 2022 - 2026
Baum Charles M Director filed 2023 - 2026
Shacham Sharon Director filed 2022 - 2026
Shah Rajeev M. Director filed 2022 - 2026
Dirocco Derek Director filed 2022 - 2026
RA Capital Nexus Fund II, L.P. Director filed 2022 - 2026
Palani Santhosh Director filed 2024 - 2026
Blume-Jensen Peter Director · President and CEO filed 2022 - 2026
Masson Kristina Director · EVP - Business Operations filed 2022 - 2026

Officers (from insider filings)

NameTitle as filedFilings
Mirza Mansoor Raza Chief Medical Officer filed 2025 - 2026
Miller Mary Chief Legal Officer filed 2023 - 2026
Gamelin Erick Chief Medical Officer filed 2022 - 2026
Devroe Eric Chief Operating Officer filed 2022 - 2026
Peterson Katharine Chief Accounting Officer filed 2024 - 2026
Levy Adam D. Chief Financial Officer filed 2025 - 2026
Cuillerot Jean-Marie Chief Medical Officer filed 2024 - 2025
Holm-Jorgensen Rasmus Chief Financial Officer filed 2022 - 2025

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.